Drug Delivery System
Online ISSN : 1881-2732
Print ISSN : 0913-5006
ISSN-L : 0913-5006
血中滞留性リポソーム封入ドキソルビシンの腹腔癌における抗腫瘍効果制御システムの構築
土橋 麻理原島 秀吉際田 弘志
著者情報
ジャーナル フリー

1999 年 14 巻 2 号 p. 109-113

詳細
抄録
There is no quantitative analysis on the relationship between antitumor effect and optimum conditions of liposomes as drug carriers. We have developed a physiological model which incorporates a cell kill kinetic model for the antitumor effects of free and liposomal DOX in mice. Antitumor effect predicted by this model showed an optimum rate of drug release from liposomes (∼10hr in half life) and this prediction was varified by animal experiments in vivo. There was a good relationship of antitumor effects between simulations and experiments, which validates our model. This model will provide useful information for optimization of drug carriers for anticancer drugs.
著者関連情報
© 日本DDS学会
前の記事 次の記事
feedback
Top